( .S. Securities and Exchange Commission...)Pediatric Academic Societies' Annual Meeting to Feature Data,Presentations Related to MedImmune Clinical Programs in Influenza,,RSV and hMPV,Health

.S. Securities and Exchange Commission, and MedImmune will file a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the offer. The tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other offer documents) and the Solicitation/Recommendation Statement will contain important information, which should be read carefully before any decision is made with respect to the tender offer. The Offer to Purchase, the related Letter of Transmittal and certain other offer documents, as well as the Solicitation/Recommendation Statement, will be made available for free at the U.S. Securities and Exchange Commission's web site at www.sec.gov, at AstraZeneca's website at www.astrazeneca.com or at MedImmune's website at www.medimmune.com.

SOURCE  MedImmune, Inc.
    -0-                             05/02/2007
    /CONTACT:  media, Karen Lancaster, +1-301-398-5864, or investors, Beatrice
Pierre, +1-301-398-4905, both of MedImmune, Inc./
    /Web site:  http://www.medimmune.com
                http://www.astrazeneca.com /
    (MEDI)

CO:  MedImmune, Inc.
ST:  Maryland, Ontario
IN:  IDC HEA MTC
SU:  TRI SVY TDS CHI

AR-MT
-- NEW050 --
0241 05/02/2007 08:15 EDT http://www.prnewswire.com

'"/>




Page: 1 2 3 4
Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
3. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
4. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
5. New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At Annual Digestive Disease Week Meeting
6. Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies Annual Meeting
7. Research Results on FluMist Presented at National Association of Pediatric Nurse Practitioners Conference
8. Replidyne Phase II Pediatric Trial Meets Primary Objective
9. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference